Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: Analyses from the 7-year PRECiSE 3 study

  • W. J. Sandborn
  • , G. Y. Melmed
  • , D. P.B. McGovern
  • , E. V. Loftus
  • , J. M. Choi
  • , J. H. Cho
  • , B. Abraham
  • , A. Gutierrez
  • , G. Lichtenstein
  • , S. D. Lee
  • , C. W. Randall
  • , D. A. Schwartz
  • , M. Regueiro
  • , C. A. Siegel
  • , M. Spearman
  • , G. Kosutic
  • , B. Pierre-Louis
  • , J. Coarse
  • , S. Schreiber

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: Analyses from the 7-year PRECiSE 3 study'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science